DiaMedica Therapeutics Inc.
About
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with a focus on preeclampsia and acute ischemic stroke. For more information please visit www.diamedica.com.
US
Two Carlson Parkway, Minneapolis, MN
55447
Public Company
45
Biotechnology Research
Stroke; Recombinant Protein; Preeclampsia; Biotech
Top Decision Makers · 7
Chief Medical Officer
Julie Krop
United States
******@***.com
Phone
(**) *** ****
Executive Director, Program Management
Marc Bellisario
United States
******@***.com
Phone
(**) *** ****
Vice President of Finance
Teri Wilson
United States
******@***.com
Phone
(**) *** ****
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.